Big Data
For Better Hearts
Menu
Home
About
Objectives
Key messages
Work packages
Case studies
Governance
Partners
News
Newsletter
Newsletters
Sign up
Webinars
Big Data for Better Hearts
The Impact of ´Long Covid´ on Cardiovascular Disease
European differences in heart failure registries
Did Generics for CVD Kill R&D?
Data Privacy
Wearables for Cardiovascular Patients - A Big Win
Making Data Sharing, AI, and Algorithms Possible
Final BD@H Webinar
Events
Publications
Contact
Members Area
Podcast
BigData@Heart
ESC Congress 2017 - Barcelona, Spain
AGENDA
11:15- 11:30 Welcome, Prof. Folkert Asselbergs, UMC Utrecht/University College London & Dr. Maureen Cronin, Vifor Pharma
11.30 - 12:05 Genetic epidemiology: Back to Basics. Prof. Folkert Asselbergs, UMC Utrecht/University College London
12:05 - 12:40 Electronic Health Records for research: concepts and opportunities for design and support of clinical trials. Dr. Spiros Denaxas, University College London
12.40 - 13:00 Lunch
13:00 - 13:35 Mendelian Randomisation. Nature's Clinical Trial for drug target validation. Dr. Dan Swerdlow, University College London
13.35 - 14.10 Redefining disease and outcome using proteomics. Tony Bartlett, Director, UK/Europe, Business Development & Strategic Collaborations, SomaLogic, Inc.
14.10 - 14.20 Tea/Coffee
14.20 - 15.00 Workshop using phenoscanner. Participants will learn basic in-silico analyses to perform look-ups of potential interesting drug targets (bring your own laptop). Dr Bram Prins, Cambridge University
15:00 Wrap up
"The Impact of ´Long Covid´ on Cardiovascular Disease – BigData@Heart"
24th November 2020